Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Association between chronic hepatitis C virus infection and bone mineral density.

Lin JC, Hsieh TY, Wu CC, Chen PJ, Chueh TH, Chang WK, Chu HC.

Calcif Tissue Int. 2012 Dec;91(6):423-9. doi: 10.1007/s00223-012-9653-y. Epub 2012 Oct 5.

PMID:
23052227
2.

Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection.

El-Maouche D, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT.

J Hepatol. 2011 Oct;55(4):770-6. doi: 10.1016/j.jhep.2011.01.035. Epub 2011 Feb 19.

3.

Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.

Ersoy FF, Passadakis SP, Tam P, Memmos ED, Katopodis PK, Ozener C, Akçiçek F, Camsari T, Ateş K, Ataman R, Vlachojannis JG, Dombros AN, Utaş C, Akpolat T, Bozfakioğlu S, Wu G, Karayaylali I, Arinsoy T, Stathakis PC, Yavuz M, Tsakiris JD, Dimitriades CA, Yilmaz ME, Gültekin M, Karayalçin B, Yardimsever M, Oreopoulos DG.

J Bone Miner Metab. 2006;24(1):79-86.

PMID:
16369903
4.

Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients.

Sit D, Kadiroglu AK, Kayabasi H, Atay AE, Yilmaz Z, Yilmaz ME.

Adv Ther. 2007 Sep-Oct;24(5):987-95.

PMID:
18029324
5.

Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C.

Lai JC, Shoback DM, Zipperstein J, Lizaola B, Tseng S, Terrault NA.

Dig Dis Sci. 2015 Jun;60(6):1813-9. doi: 10.1007/s10620-014-3507-6. Epub 2015 Jan 7.

6.

Bone mineral density in patients on maintenance hemodialysis and effect of chronic hepatitis C virus infection.

Yücel AE, Kart-Köseoglu H, Isiklar I, Kuruinci E, Ozdemir FN, Arslan H.

Ren Fail. 2004 Mar;26(2):159-64.

PMID:
15287200
7.

Areal bone mineral density in pediatric patients with chronic hepatitis B or chronic hepatitis C.

Mora S, Giacomet V, Viganò A, Maruca K, Capelli S, Nannini P, Zuccotti GV.

Calcif Tissue Int. 2014 Sep;95(3):218-21. doi: 10.1007/s00223-014-9884-1. Epub 2014 Jun 24.

PMID:
24958473
8.

Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease.

Duarte MP, Farias ML, Coelho HS, Mendonça LM, Stabnov LM, do Carmo d Oliveira M, Lamy RA, Oliveira DS.

J Gastroenterol Hepatol. 2001 Sep;16(9):1022-7.

PMID:
11595067
9.

Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.

Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodés J, Muñoz-Gómez J.

Calcif Tissue Int. 1997 Feb;60(2):148-54.

PMID:
9056162
10.

Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.

Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L.

Am J Med. 1996 Sep;101(3):262-9.

PMID:
8873487
11.

Effect of chronic hepatitis C virus infection on bone mineral density in pediatric renal transplant recipients.

El-Husseini A, Sabry A, Hassan R, Sobh M.

Saudi J Kidney Dis Transpl. 2013 Sep;24(5):917-24.

12.

Femoral neck osteopenia in patients with inflammatory bowel disease.

Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D.

Am J Gastroenterol. 1998 Sep;93(9):1483-90.

PMID:
9732930
13.

Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection.

Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, Wiese M, Moessner J.

World J Gastroenterol. 2005 Mar 28;11(12):1843-7.

14.

Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome.

Minetto M, Reimondo G, Osella G, Ventura M, Angeli A, Terzolo M.

Osteoporos Int. 2004 Nov;15(11):855-61. Epub 2004 Mar 18.

PMID:
15034643
15.

Bone mineral density and metabolism in familial dysautonomia.

Maayan C, Bar-On E, Foldes AJ, Gesundheit B, Pollak RD.

Osteoporos Int. 2002 May;13(5):429-33.

PMID:
12086355
16.

The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt.

Raslan HM, Elhosary Y, Ezzat WM, Rasheed EA, Rasheed MA.

Trans R Soc Trop Med Hyg. 2010 Jun;104(6):429-32. doi: 10.1016/j.trstmh.2010.01.012. Epub 2010 Mar 1.

PMID:
20189618
17.

Regional bone mineral density after orthotopic liver transplantation.

Hussaini SH, Oldroyd B, Stewart SP, Roman F, Smith MA, Pollard S, Lodge P, O'Grady JG, Losowsky MS.

Eur J Gastroenterol Hepatol. 1999 Feb;11(2):157-63.

PMID:
10102226
18.

Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.

Dresner-Pollak R, Karmeli F, Eliakim R, Ackerman Z, Rachmilewitz D.

Am J Gastroenterol. 2000 Mar;95(3):699-704.

PMID:
10710060
19.

Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.

Colao A, Di Somma C, Loche S, Di Sarno A, Klain M, Pivonello R, Pietrosante M, Salvatore M, Lombardi G.

Clin Endocrinol (Oxf). 2000 Mar;52(3):319-27.

PMID:
10718830
20.

Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease.

Smith DL, Shire NJ, Watts NB, Schmitter T, Szabo G, Zucker SD.

J Clin Densitom. 2006 Jan-Mar;9(1):105-13. Epub 2006 Mar 27.

PMID:
16731439

Supplemental Content

Support Center